Fundraising Fox

Metcela

5 known investors

Find your way into Metcela

Metcela is a Japanese biotech company developing science-backed therapies for pediatric and rare diseases, with in-house capabilities spanning research through development. Its work builds on regenerative medicine and cardiac stem cell development expertise.

BiotechHealthtechMedical Devices

Investors · 5

Beyond Next VenturesTokyo
F-Prime CapitalCambridge · $3M – $10M
OSAKA University Venture CapitalOsaka · $3M – $142M
Sony Ventures CorporationTokyo
UTECTokyo · $3.1M – $78M

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Metcela Eligible to Receive up to $7 Million (1 Billion JPY) AMED Grant for Promoting the Development of Regenerative Medicine Product Using Cardiac Stem Cells | Metcela Inc.metcela.com · Nov 2022Metcela Closes $14M Series C Financing - FinSMEsfinsmes.com · Jul 2022Metcela Inc. Completes the Series C Financing of Total $14 Million | Metcela Inc.metcela.com · Jun 2022Metcela Raises $12.7M in Series B Financing - FinSMEsfinsmes.com · Jan 2021Metcela Raised $4 Million in Series B Funding to Launch a Phase I Clinical Trial for Heart Failure Therapy | Metcela Inc.metcela.com · May 2020Metcela raises 520 million yen in Series A financing round | Metcela Inc.metcela.com · Sep 2018

Frequently asked questions

What does Metcela do?
Metcela is a Japanese biotech company developing science-backed therapies for pediatric and rare diseases, with in-house capabilities spanning research through development. Its work builds on regenerative medicine and cardiac stem cell development expertise.
Who are Metcela's investors?
Metcela's investors include Beyond Next Ventures, F-Prime Capital, OSAKA University Venture Capital, Sony Ventures Corporation, UTEC.